EFFECT OF DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE ON CARDIAC FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH CARDIAC INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY

Martha Grogan; Mathew S. Maurer; Ronald Witteles; Divaya Bhutani; Raymond L. Comenzo; Angela Dispenzieri; Arnaud Jaccard; Efstathios Kastritis; Michaela Liedtke; Giampaolo Merlini; Monique C. Minnema; Vaishali Sanchorawala; Katharine S. Gries; Xiang Qin; Huiling Pei; NamPhuong Tran; Brendan M. Weiss; Ashutosh D. Wechalekar

doi:10.1016/s0735-1097(21)04658-1

EFFECT OF DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE ON CARDIAC FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH CARDIAC INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)04658-1 ◽

2021 ◽

Vol 77 (18) ◽

pp. 3304

Author(s):

Martha Grogan ◽

Mathew S. Maurer ◽

Ronald Witteles ◽

Divaya Bhutani ◽

Raymond L. Comenzo ◽

...

Keyword(s):

Quality Of Life ◽

Cardiac Function ◽

Cardiac Involvement ◽

Al Amyloidosis ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial

The Lancet Haematology ◽

10.1016/s2352-3026(20)30356-2 ◽

2020 ◽

Vol 7 (12) ◽

pp. e874-e883

Author(s):

Murielle Roussel ◽

Philippe Moreau ◽

Benjamin Hebraud ◽

Kamel Laribi ◽

Arnaud Jaccard ◽

...

Keyword(s):

Quality Of Life ◽

Newly Diagnosed ◽

Health Related Quality ◽

Life Outcomes ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

Health-Related Quality of Life in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients Treated with Either Thalidomide or Lenalidomide-Based Regimen Until Progression (HOVON-87/NMSG18 Study): A Prospective, Open-Label, Multicenter, Randomized, Phase 3 Study

SSRN Electronic Journal ◽

10.2139/ssrn.3337896 ◽

2019 ◽

Author(s):

Lene Kongsgaard Nielsen ◽

Claudia Stege ◽

Birgit Lissenberg-Witte ◽

Bronno van der Holt ◽

Ulf-Henrik Mellqvist ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Newly Diagnosed ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(19)30502-9 ◽

2019 ◽

Vol 20 (10) ◽

pp. 1444-1453 ◽

Cited By ~ 4

Author(s):

Johannes Weller ◽

Theophilos Tzaridis ◽

Frederic Mack ◽

Joachim Peter Steinbach ◽

Uwe Schlegel ◽

...

Keyword(s):

Quality Of Life ◽

Neurocognitive Functioning ◽

Newly Diagnosed ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

Haematologica ◽

10.3324/haematol.2019.222299 ◽

2019 ◽

Vol 105 (6) ◽

pp. 1650-1659 ◽

Cited By ~ 2

Author(s):

Lene Kongsgaard Nielsen ◽

Claudia Stege ◽

Birgit Lissenberg-Witte ◽

Bronno van der Holt ◽

Ulf-Henrik Mellqvist ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Newly Diagnosed ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

Faculty Opinions recommendation of Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969674.793470152 ◽

2013 ◽

Author(s):

Christopher Steer

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

HEALTH‐RELATED QUALITY OF LIFE AMONG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL) IN A PHASE 3 STUDY OF PEMBROLIZUMAB VERSUS BRENTUXIMAB VEDOTIN

Hematological Oncology ◽

10.1002/hon.105_2880 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

P. L. Zinzani ◽

M. Raut ◽

T. Saretsky ◽

R. Ramchandren ◽

A. Santoro ◽

...

Keyword(s):

Quality Of Life ◽

Hodgkin Lymphoma ◽

Brentuximab Vedotin ◽

Classical Hodgkin Lymphoma ◽

Health Related Quality ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

Critical Review of Factors Predicting Health-Related Quality of Life in Newly Diagnosed Coronary Artery Disease Patients

The Journal of Cardiovascular Nursing ◽

10.1097/jcn.0b013e31824af56e ◽

2013 ◽

Vol 28 (3) ◽

pp. 277-284 ◽

Cited By ~ 32

Author(s):

Padthayawad Pragodpol ◽

Catherine Ryan

Keyword(s):

Quality Of Life ◽

Coronary Artery Disease ◽

Coronary Artery ◽

Critical Review ◽

Newly Diagnosed ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

Artery Disease

Download Full-text

27078 Mediation analysis of independent treatment effect of guselkumab on health-related quality of life in patients with moderate to severe plaque-type psoriasis: Results from 2 phase 3 studies VOYAGE-1&2

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.532 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB128

Author(s):

April W. Armstrong ◽

Yan Liu ◽

Nan Li ◽

Kristian Reich ◽

Peter Foley ◽

...

Keyword(s):

Quality Of Life ◽

Treatment Effect ◽

Mediation Analysis ◽

Health Related Quality ◽

Phase 3 ◽

Plaque Type ◽

Related Quality ◽

Health Related

Download Full-text

Su1385 Effect of Eluxadoline on Health-Related Quality of Life in Adults With Irritable Bowel Syndrome With Diarrhea: Results From Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials

Gastroenterology ◽

10.1016/s0016-5085(15)31656-5 ◽

2015 ◽

Vol 148 (4) ◽

pp. S-494 ◽

Cited By ~ 2

Author(s):

David Andrae ◽

Jessica L. Buono ◽

Paul S. Covington

Keyword(s):

Quality Of Life ◽

Irritable Bowel Syndrome ◽

Health Related Quality ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Related Quality ◽

Health Related ◽

Irritable Bowel

Download Full-text

Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjy135 ◽

2018 ◽

Vol 13 (1) ◽

pp. 139-140 ◽

Cited By ~ 1

Author(s):

Julian Panés ◽

Séverine Vermeire ◽

James O Lindsay ◽

Bruce E Sands ◽

Chinyu Su ◽

...

Keyword(s):

Quality Of Life ◽

Ulcerative Colitis ◽

Health Related Quality ◽

Phase 3 ◽

Related Quality ◽

Health Related ◽

Randomised Controlled

Download Full-text